Non-Applicability of Regulations 32 of SEBI (LODR)
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Kabra Drugs Ltd has submitted a compliance certificate to BSE confirming that Regulation 32 of SEBI (LODR) Regulations, 2015 is not applicable for the quarter ended 31st March 2026. This regulation requires listed companies to disclose deviations in the use of proceeds from public issues, rights issues, or preferential issues. The Managing Director, Mr. Nanjappan Aravind, has certified that the company did not raise any funds through such issuances during this period, making the disclosure requirement inapplicable.
Neutral for shareholders. The company confirms it has not issued new shares or raised capital via public/rights/preferential issues this quarter, so there are no fund utilization deviations to report.